The committee will discuss bulk drug substances nominated for inclusion on the 503A Bulks List and revisions FDA is considering to the Withdrawn or Removed List.
Back to All Events
Earlier Event: May 27
Endocrinologic and Metabolic Drugs Advisory Committee
Later Event: June 10
Vaccines and Related Biological Products Advisory Committee